NCT04765696 (RELOC-AGE) is a clinical trial of No intervention is administered in Active Ageing, sponsored by Lund University.

Who is sponsoring NCT04765696?

NCT04765696 is sponsored by Lund University.

What drugs are being tested in NCT04765696?

Interventions in NCT04765696: No intervention is administered.

What condition does NCT04765696 study?

NCT04765696 studies Active Ageing.

Is NCT04765696 still recruiting?

NCT04765696 is currently active, enrolled. Last updated 11 March 2025.

Last reviewed 2025-03-11 · How we verify

NCT04765696: RELOC-AGE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective RELOC-AGE: How Do Housing Choices and Relocation Matter for Active Ageing?

Active, enrolled Last updated 11 March 2025

What this trial tests

trial testing No intervention is administered in Active Ageing in 1,964 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 March 2021

Primary endpoint
31 December 2028

30 June 2029

Quick facts

Lead sponsor	Lund University
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	1,964
Start date	1 March 2021
Primary completion	31 December 2028
Estimated completion	30 June 2029
Sites	1 location across Sweden

Drugs / interventions tested

No intervention is administered

Conditions studied

Active Ageing — all drugs for Active Ageing →

Sponsor

Lund University

Who can join

55 and older, any sex, with Active Ageing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of prospective RELOC-AGE is to study housing choices and relocation and to examine the effects on active ageing among people aged 55+ considering relocation. All data collection will be conducted at baseline and after 1, 3, 5 and 7 years of follow-up.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Exploring Associations of Housing, Relocation, and Active and Healthy Aging in Sweden: Protocol for a Prospective Longitudinal Mixed Methods Study.
Zingmark M, Björk J, Granbom M, Gefenaite G, et al · · 2021 · cited 11× · PMID 34546172 · DOI 10.2196/31137
Challenges related to self-assessment of active ageing during the Covid-19 pandemic in Sweden.
Zingmark M, Nordeström F, Iwarsson S. · · 2022 · cited 5× · PMID 35562784 · DOI 10.1186/s13104-022-06059-3
Translation and Psychometric Evaluation of the University of Jyvaskyla Active Aging Scale (UJACAS) for Use in Sweden.
Nordeström F, Slaug B, Zingmark M, Granbom M, et al · · 2024 · cited 4× · PMID 38252386 · DOI 10.1007/s10823-024-09496-8
Meaning of home attenuates the relationship between functional limitations and active aging.
Slaug B, Zingmark M, Granbom M, Björk J, et al · · 2024 · cited 1× · PMID 39088106 · DOI 10.1007/s40520-024-02810-x
Relationship Between Active Aging and Perceived Aspects of Home Among Persons Aged 55+ Listed With an Interest in Relocation.
Nordeström F, Slaug B, Zingmark M, Granbom M, et al · · 2025 · PMID 40894461 · DOI 10.1177/30495334251366584

Verify or expand the search:

Other Lund University trials

Trials by the same sponsor.

NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
NCT07425925 — Digital Peer-support-based Anti-HIV Stigma Intervention Among Adolescents Living With HIV in Ethiopia · NA · recruiting
NCT07407842 — UPSIDES - Recovery Through Peer Support · NA · enrolling by invitation
NCT07141108 — Self-monitoring and Remote Monitoring of Chronic Pain in Primary Care - Using a Digital Tool to Improve Quality of Life · NA · recruiting
NCT07025694 — Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04765696 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lund University
Last refreshed: 11 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04765696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing